Merck Stock Performance

MRK
 Stock
  

USD 93.13  0.49  0.53%   

Merck has a performance score of 7 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.5041, which conveys possible diversification benefits within a given portfolio. Let's try to break down what Merck's beta means in this case. As returns on the market increase, Merck returns are expected to increase less than the market. However, during the bear market, the loss on holding Merck will be expected to be smaller as well. Although it is important to respect Merck Company price patterns, it is better to be realistic regarding the information on the equity's historical price patterns. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Merck Company technical indicators, you can presently evaluate if the expected return of 0.14% will be sustainable into the future. Merck Company right now secures a risk of 1.41%. Please verify Merck Company value at risk, as well as the relationship between the skewness and day median price to decide if Merck Company will be following its current price movements.
  
Refresh
Merck Performance
7 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Merck Company are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Merck may actually be approaching a critical reversion point that can send shares even higher in August 2022. ...more

Merck Price Channel

Quick Ratio0.90
Fifty Two Week Low70.89
Target High Price115.00
Fifty Two Week High95.72
Payout Ratio48.91%
Trailing Annual Dividend Yield2.85%
Target Low Price76.00

Merck Relative Risk vs. Return Landscape

If you would invest  8,610  in Merck Company on April 7, 2022 and sell it today you would earn a total of  703.00  from holding Merck Company or generate 8.16% return on investment over 90 days. Merck Company is generating 0.1385% of daily returns assuming volatility of 1.4133% on return distribution over 90 days investment horizon. In other words, 12% of stocks are less volatile than Merck, and above 98% of all equities are expected to generate higher returns over the next 90 days.
 Daily Expected Return (%) 
      Risk (%) 
Considering the 90-day investment horizon Merck is expected to generate 0.97 times more return on investment than the market. However, the company is 1.03 times less risky than the market. It trades about 0.1 of its potential returns per unit of risk. The DOW is currently generating roughly -0.11 per unit of risk.

Merck Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Merck's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Merck Company, and traders can use it to determine the average amount a Merck's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.098

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
MRKHigh
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 1.41
  actual daily
 
 12 %
of total potential
 
1212
Expected Return
 0.14
  actual daily
 
 2 %
of total potential
 
22
Risk-Adjusted Return
 0.1
  actual daily
 
 7 %
of total potential
 
77
Based on monthly moving average Merck is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Merck by adding it to a well-diversified portfolio.

About Merck Performance

To evaluate Merck Company Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Merck generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Merck Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Merck Company stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Merck's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Effect of Exchange Rate Changes on Cash-133 M-143.5 M
Return on Investment 19.53  21.07 
Return on Average Assets 0.14  0.11 
Return on Average Equity 0.39  0.31 
Return on Invested Capital 0.26  0.23 
Return on Sales 0.30  0.28 
Merck Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC Bayer AG Eisai Co., Ltd. Ridgeback Biotherapeutics and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Things to note about Merck Company

Checking the ongoing alerts about Merck for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Merck Company help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Merck Alerts

Equity Alerts and Improvement Suggestions

Merck Company was previously known as MERCK INC and was traded on New York Stock Exchange under the symbol MRK.
Merck Company has a strong financial position based on the latest SEC filings
Over 75.0% of the company shares are owned by institutional investors
Latest headline from investorplace.com: 6 Recession-Proof Stocks to Buy as the Market Boom Ends - InvestorPlace
Additionally, see Stocks Correlation. Note that the Merck Company information on this page should be used as a complementary analysis to other Merck's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Merck Stock analysis

When running Merck Company price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine Merck value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.